Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: A receptor binding and quantitative autoradiographic study

Neuropsychopharmacology

Volumn 18, Issue 4, 1998, Pages 305-316

  Bancroft, Gregory N ^a   Morgan, Kimberly A ^a   Flietstra, Rebecca J ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

3H 7 OH DPAT; 3H PD 128907; D3 dopamine receptor; Rat brain; Receptor autoradiography; Receptor binding

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BRAIN RECEPTOR; BUTACLAMOL; DOMPERIDONE; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE; HALOPERIDOL; QUINPIROLE; RADIOLIGAND; SPIPERONE; TRITIUM; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H (1)BENZOPYRANO(4,3 B) 1,4 OXAZIN 9 OL; 3,4,4A,10B-TETRAHYDRO-4-PROPYL-2H,5H-(1)BENZOPYRANO(4,3-B)-1,4-OXAZIN-9-OL; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; BENZOPYRAN DERIVATIVE; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, RAT; LIGAND; MESSENGER RNA; OXAZINE DERIVATIVE; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CORPUS STRIATUM; DRUG POTENCY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BINDING; ANIMAL; BIOSYNTHESIS; BRAIN LEVEL; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; METABOLISM; NEOSTRIATUM; SPRAGUE DAWLEY RAT;

ANIMALS; AUTORADIOGRAPHY; BENZOPYRANS; BRAIN; BRAIN CHEMISTRY; DOPAMINE AGONISTS; GUANINE NUCLEOTIDES; LIGANDS; MALE; NEOSTRIATUM; OXAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER; TETRAHYDRONAPHTHALENES;

EID: 0031594426     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00162-0     Document Type: Article

References (33)

1. 3 receptor agonist ligand, to CHO-K1 cells. Life Sci. 57:1995;1401-1410.
2. Bennett JP, Yamamura HI Neurotransmitter, hormone, or drug receptor binding methods. Yamamura HI, Enna SJ, Kuhar MJ Neurotransmitter Receptor Binding. 1985;61-89 Raven Press, New York.
3. 125I]iodosulpiride Synapse. 19:1995;1-13.
4. 3 dopamine receptor. Pharmacologic properties and development of antibodies J Pharmacol Exp Ther. 264:1993;1002-1011.
5. 2 receptor mRNA Brain Res. 564:1991;302-319.
6. 3 dopamine receptors. Neuropsychopharmacology. 12:1995;335-345.
7. Caine SB, Koob GF Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science. 260:1993;1814-1816.
8. Curran EJ, Watson SJ Jr. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat. A double in situ hybridization study J Comp Neurol. 361:1995;57-76.
9. 3 receptor in the rat brain. Neuroscience. 65:1995;731-745.
10. 3 dopamine receptor. J Pharmacol Exp Ther. 286:1994;417-426.
11. 3 receptors. Eur J Pharmacol. 272:1995;R1-R3.
12. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine. J Neurosci. 6:1986;1757-1770.
13. 3H]PD 128907. Psychopharmacology. 128:1996;240-247.
14. Heimer L, Zahm DS, Alheid GF Basal ganglia. Paxinos G The Rat Central Nervous System. 1995;579-628 Academic Press, San Diego, CA.
15. Landwehrmeyer B, Mengood G, Palacios JM Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur J Neurosci. 5:1993;145-153.
16. 3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Brain Res. 698:1995;146-154.
17. Levant B Distribution of dopamine receptor subtypes in the CNS. Stone TW CNS Neurotransmitters and Neuromodulators, Dopamine. 1996;77-87 CRC Press, Boca Raton, FL.
18. 3 receptors Synapse. 14:1993;90-95.
19. 2-like dopamine receptors in rat brain. J Pharmacol Exp Ther. 262:1992;929-935.
20. 3 dopamine receptors in rat brain and pituitary gland. A quantitative autoradiographic study J Pharmacol Exp Ther. 264:1993;991-1001.
21. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci USA. 89:1992;8155-8159.
22. 3 receptor expressed in transfected cell lines. Eur J Pharmacol-Mol Pharmacol. 266:1994;79-85.
23. 3 receptor mRNAs in human and rat brain. Neurochem Int. 20:1992;33s-43s.
24. 3 receptors in rat brain. Eur J Pharmacol. 234:1993;269-272.
25. Paxinos G, Watson C The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, Sydney.
26. Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW, Demaattos SB, Corbin AE, Glase SA, Wise LD, Dijkstra D, Heffner TG Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J Pharmacol Exp Ther. 275:1995;1355-1366.
27. Seeman P, Grigoriadis D Dopamine receptors in brain and periphery. Neurochem Int. 10:1987;1-25.
28. 2 dopaminergic receptors. J Biol Chem. 258:1983;4957-4965.
29. Sibley DR, Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci. 13:1992;61-69.
30. 2 receptor Eur J Pharmacol. 225:1992;331-337.
31. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
32. Stevens JR An anatomy of schizophrenia? Arch Gen Psychiatry. 29:1973;177-189.
33. 3H]propyl-2-aminotetralin and carbetapentane. J Neurochem. 64:1995;700-710.